Has the Time for At-Home Cancer Care Finally Come?
A Penn Medicine team debuts its program focused on cancer care at home — just in time for COVID-19.
Head and Neck Cancer
HEAD AND NECK CANCER ADVISOR
FEATURED CONTENT
-
-
Genomics Industry Tries New Strategies to Engage Community Oncologists
Streamlined prescribing and reimbursement, patient education tools aim to overcome barriers to adoption of genetic testing. -
A New Look at the Dose-Response Relationship in Phase 1 Oncology Trials
The new generation of cancer drugs behave quite differently than cytotoxic therapies, and that may mean phase 1 trials need to be updated. -
Researchers Turn to Crowdsourcing to Learn More About COVID-19 and Cancer
Pooling data from physicians and patients appears to be an efficient way to answer urgent questions. -
Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation
The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing.
HEAD AND NECK CANCER NEWS
Immunoradiotherapy May Be a Promising Option in Cisplatin-Ineligible Head and Neck Cancer
Gardasil 9 Approved to Prevent Certain HPV-Related Head and Neck Cancers
New Dosing Schedule Approved for All Keytruda Indications
Promising Clinical Activity for RT Plus ICIs in Locally Advanced Head and Neck Cancers
Short-Term Mortality Risks Appear Higher in HPV-Negative Oropharyngeal Cancer
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Head and Neck Cancer
